Literature DB >> 34483048

HCV egress - unconventional secretion of assembled viral particles.

Maximilian Bunz1, Michael Ritter1, Michael Schindler2.   

Abstract

It is believed that hepatitis C virus (HCV) particles are released through the canonical secretory route: from the endoplasmic reticulum (ER), via the Golgi, to the plasma membrane. While the Golgi is important for HCV release per se, its direct involvement in the trafficking of assembled virions has not yet been established. In fact, data from studies analyzing HCV egress are compatible with several potential pathways of HCV secretion. Here, we summarize and discuss the current knowledge related to the HCV export pathway. Apart from the prototypical anterograde transport, possible routes of HCV release include ER-to-endosomal transport, secretory autophagy, and poorly described mechanisms of unconventional protein secretion. Studying HCV egress promises to shed light on unconventional cellular trafficking and secretory routes.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  exocytosis; hepatitis C virus; intracellular trafficking; noncanonical export pathways; release; secretion; unconventional protein secretion

Mesh:

Year:  2021        PMID: 34483048     DOI: 10.1016/j.tim.2021.08.005

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  2 in total

1.  Evidence for the role of Rab11-positive recycling endosomes as intermediates in coronavirus egress from epithelial cells.

Authors:  Jaakko Saraste; Mary Enyioko; Hege Dale; Kristian Prydz; Carolyn Machamer
Journal:  Histochem Cell Biol       Date:  2022-05-23       Impact factor: 2.531

2.  Hepatitis C Virus-Induced ROS/JNK Signaling Pathway Activates the E3 Ubiquitin Ligase Itch to Promote the Release of HCV Particles via Polyubiquitylation of VPS4A.

Authors:  Lin Deng; Yujiao Liang; Adi Ariffianto; Chieko Matsui; Takayuki Abe; Masamichi Muramatsu; Takaji Wakita; Masatoshi Maki; Hideki Shibata; Ikuo Shoji
Journal:  J Virol       Date:  2022-01-19       Impact factor: 6.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.